Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 167

Results For "CAS"

1711 News Found

Zydus new initiative to safeguard patients against counterfeit drugs
News | May 29, 2021

Zydus new initiative to safeguard patients against counterfeit drugs

The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website


TLC partners Strides to launch Mucormycosis drug in India
News | May 28, 2021

TLC partners Strides to launch Mucormycosis drug in India

Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides


Remdesivir demand was exaggerated: Dr. Sharvil Patel
News | May 28, 2021

Remdesivir demand was exaggerated: Dr. Sharvil Patel

Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines


Bharat Biotech signs MoU with GCVC for COVID Vaccine
News | May 28, 2021

Bharat Biotech signs MoU with GCVC for COVID Vaccine

It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN


Pfizer registers Q4FY21net profit at Rs 100 Cr
News | May 26, 2021

Pfizer registers Q4FY21net profit at Rs 100 Cr

Revenue from operations for the year ended March 31, 2021 is ?2,239 crore


Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma
News | May 25, 2021

Orchid Pharma to transfer IKKT undertaking to JV with Bionpharma

The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr


Cipla to market Roche's Antibody Cocktail in India
Policy | May 25, 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19


Balaxi records Q4 FY21 revenue of Rs. 53 Cr
News | May 22, 2021

Balaxi records Q4 FY21 revenue of Rs. 53 Cr

Drop in revenue in the fourth quarter is normal as China is shut down for most of the quarter due to the Chinese New Year holiday


Outlook promising for Cipla: HDFC Securities
News | May 18, 2021

Outlook promising for Cipla: HDFC Securities

The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.


Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities
News | May 18, 2021

Sputnik V launch to lift near-term outlook for Dr. Reddy's Labs: HDFC Securities

Dr. Reddy's has the rights to distribute 250mn doses in India